Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BCG
Pharma
Takeda, Lilly-Innovent, BIO-China—Fierce Pharma Asia
Takeda launched a restructuring. Innovent notched positive data for a GLP-1R/GCGR agonist. BIO warned of the harm from cutting off Chinese CDMOs.
Angus Liu
May 10, 2024 9:30am
Merck's BCG monopoly could end
May 3, 2024 10:50am
Drugmakers urged to boost production of key bladder cancer drug
Feb 16, 2023 9:00am
New Merck plant will triple supply of scarce bladder cancer med
Oct 15, 2020 8:45am
Merck limits bladder cancer drug as demand exceeds supply
Mar 14, 2019 11:04am
GSK tuberculosis vaccine shows promise in phase 2b
Sep 26, 2018 7:15am
